Photo taken from: Luigi Lorini/LinkedIn
Nov 27, 2023, 20:28
Luigi Lorini: What is the role of ICIs in patients excluded from clinical trials?
Luigi Lorini, Medical Oncologist at Humanitas Research Hospital, made the following post on LinkedIn:
“The introduction of ICIs has significantly altered the therapeutic scenario for patients with advanced cSCC.
Nevertheless, there are crucial aspects that need further exploration. How can ICIs be integrated into a curative setting? What is the role of ICIs in patients excluded from clinical trials?
You can find our latest manuscript on this intriguing topic here!”
Source: Luigi Lorini/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 23:18
Nov 13, 2024, 19:25
Nov 13, 2024, 16:51
Nov 13, 2024, 16:49
Nov 13, 2024, 16:45
Nov 13, 2024, 16:25
Nov 13, 2024, 16:23